Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orchestra BioMed Holdings (OBIO) Share-based Compensation: 2022-2024

Historic Share-based Compensation for Orchestra BioMed Holdings (OBIO) over the last 3 years, with Dec 2024 value amounting to $10.6 million.

  • Orchestra BioMed Holdings' Share-based Compensation rose 27.45% to $3.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.1 million, marking a year-over-year increase of 40.52%. This contributed to the annual value of $10.6 million for FY2024, which is 39.21% up from last year.
  • Per Orchestra BioMed Holdings' latest filing, its Share-based Compensation stood at $10.6 million for FY2024, which was up 39.21% from $7.6 million recorded in FY2023.
  • In the past 5 years, Orchestra BioMed Holdings' Share-based Compensation ranged from a high of $10.6 million in FY2024 and a low of $3.4 million during FY2022.
  • In the last 3 years, Orchestra BioMed Holdings' Share-based Compensation had a median value of $7.6 million in 2023 and averaged $7.2 million.
  • Data for Orchestra BioMed Holdings' Share-based Compensation shows a peak YoY spiked of 125.93% (in 2023) over the last 5 years.
  • Over the past 3 years, Orchestra BioMed Holdings' Share-based Compensation (Yearly) stood at $3.4 million in 2022, then surged by 125.93% to $7.6 million in 2023, then surged by 39.21% to $10.6 million in 2024.